• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

FTC request may signal trouble for Novo/Catalent deal

cafead

Administrator
Staff member
  • cafead   May 30, 2024 at 11:22: AM
via The proposed deal between Novo Holdings and contract manufacturer Catalent may face headwinds from an increasingly aggressive U.S. Federal Trade Commission.

article source